Skip to main content
Home hosted by UNOPS Stop TB Partnership
  • Who We Are
    • Stop TB Partnership
      • Our Journey
      • Action Plan
      • Work with us
    • The Secretariat
    • The Board
      • Board Members
      • Board Meetings
      • Board Committees
      • Board Delegations
        • Affected Communities Delegation to the Stop TB Partnership Board
        • Developing Country NGO Delegation to the Stop TB Partnership Board
        • Developed Country NGO Delegation to the Stop TB Partnership Board
        • Key and Vulnerable Populations Constituency to the Stop TB Partnership Board
        • Private Sector Providers Constituency Delegation to the Stop TB Partnership Board
        • Innovations Constituency Delegation to the Stop TB Partnership Board
      • Report of Decision Points
      • Board Affairs Documents
    • Stop TB Working Groups
      • Child and Adolescent TB
      • End TB Transmission Initiative
        • ETTi Working Group Team
        • ETTi - Technical Readings
        • ETTi - TB and Airborne Workshops & Webinars
        • ETTi - TB and Airborne IPC Guidance
        • ETTi - Virtual library of good practices
        • ETTi - Meetings & Events
        • ETTi - Newsletters & Social Media
        • ETTi - Feedback
      • Global Drug-resistant TB Initiative
      • Global Laboratory Initiative (GLI)
      • New Diagnostics
      • New TB Drugs
      • New TB Vaccines
      • Public-Private Mix (PPM) For TB Care and Prevention
  • What we do
    • Advocate to #EndTB
      • Advocacy and Communications
      • World TB Day
      • UN High-Level Meeting on TB
        • UN High-Level Meeting on TB 2023
      • Global Fund Disease Split
      • Global Plan to End TB
      • Step up for TB: National TB Policies
      • Tuberculosis Research Funding Trends, 2005-2022
      • Hello Kitty
      • The G20
    • Prioritise People, Human Rights & Gender
      • Fund TB communities & civil society
      • Community-Led Monitoring
      • Promote Human Rights in TB
      • Support Gender Equity in TB
      • End TB Stigma
      • Reach Key & Vulnerable Populations
      • Empower TB Affected Communities & Civil Society
      • Strengthen Country-level Partnerships
      • Award those who care
    • Accelerate TB innovations
      • TB REACH
        • How TB REACH Works
        • The Team
        • TB REACH Impact
        • Catalyzing Diagnostic Use
        • Ground Up Innovation
        • Monitoring Success
        • Waves of funding
        • TB Reach publications
      • Re-imagining TB care
      • Digital Health Technology Hub
        • AI-POWERED COUGH SOUND ANALYSIS AND MONITORING
        • AI-Powered Computer-Aided Detection (CAD) Software
        • Community-Led Monitoring Tools
        • Diagnostics Connectivity Solutions
        • Digital Adherence Technologies
        • Global DAT Task Force
      • The Introducing New Tools Project
    • Facilitate Access to TB Drugs & Diagnostics
      • Global Drug Facility (GDF)
        • Mission
        • Market & Partner Coordination
        • Buyers
        • Suppliers
        • New Tools
        • Technical Assistance
        • Products Catalog
    • Provide technical support and capacity building
  • Partner With Us
    • Why Become a Partner
    • How to become a Partner
    • The benefits of partnership
    • Our Partners
    • Joining Forces to #EndTB
      • Additional resources
  • Resources
    • World TB Day
    • Interactive TB data
      • Interactive Country Dashboard
      • Interactive Map Dashboard
      • Treatment Dashboard
    • Digital TB Assessment
    • GDF Resources
    • TB & COVID
    • Publications
    • Governance of TB programs
    • UNHLM Targets & Commitments
    • COMMUNITIES, RIGHTS AND GENDER
    • At A Glance
    • What is Tuberculosis?
  • News
    • News
    • Events
    • Newsletter
  • Donate
  1. Home
  2. Site map
  • Who We Are
    • Stop TB Partnership
      • Our Journey
      • Action Plan
      • Work with us
    • The Secretariat
    • The Board
      • Board Members
      • Board Meetings
        • 25-26 March 2023, Varanasi, India
        • 19-20 May 2022, Hybrid
        • 28-30 September 2021, Virtual
        • 18-20 November 2020, Virtual
        • 11-12 December 2019, Jakarta, Indonesia
        • January 2019: Geneva, Switzerland
        • March 2018: New Delhi, India
        • 17-18 May 2017: Berlin, Germany
        • 19-20 September 2016: New York, USA
        • 29 November 2015: Cape Town, South Africa
        • 14-15 April 2015: Paris, France
        • 15 July 2014, Seattle, USA
        • 14 July 2014, Seattle, USA (Retreat)
        • January 2014, Cape Town, South Africa
        • July 2013, Ottawa, Canada
        • July 2013, Ottawa, Canada (Retreat)
        • November 2012: Kuala Lumpur, Malaysia
        • January 2012: Bangkok, Thailand
        • January 2012: Bangkok, Thailand (Retreat)
        • March / April 2011: Washington DC, USA
        • October 2010: Johannesburg, South Africa
        • May 2010: Hanoi, Viet Nam
        • November 2009: Geneva, Switzerland
        • March 2009: Rio de Janeiro, Brazil
        • October 2008: Bagamoyo, Tanzania
        • May 2008: Cairo, Egypt
        • October 2007: Berlin, Germany
        • April 2007: Geneva, Switzerland
        • November 2006: Jakarta, Indonesia
        • April 2006: Abuja, Nigeria
        • November 2005: Assisi, Italy
        • May 2005: Addis Ababa, Ethiopia
        • October 2004: Beijing, China
        • March 2004: New Delhi, India
        • October 2003: The Hague, Netherlands
        • April 2003: Brasilia, Brazil
        • October 2002: Cape Town, South Africa
        • February 2002: Osaka, Japan
        • Other meetings
        • 12-14 December 2024, Abuja, Nigeria
      • Board Committees
        • Executive Committee
          • Executive Committee Minutes
        • Finance Committee
      • Board Delegations
        • Affected Communities Delegation to the Stop TB Partnership Board
        • Developing Country NGO Delegation to the Stop TB Partnership Board
        • Developed Country NGO Delegation to the Stop TB Partnership Board
          • Work of the Developed Country NGO Delegation to the Stop TB Partnership Board
        • Key and Vulnerable Populations Constituency to the Stop TB Partnership Board
        • Private Sector Providers Constituency Delegation to the Stop TB Partnership Board
        • Innovations Constituency Delegation to the Stop TB Partnership Board
      • Report of Decision Points
      • Board Affairs Documents
    • Stop TB Working Groups
      • Child and Adolescent TB
        • 2021 Virtual annual meeting
        • 2020 Virtual annual meeting
        • 2019 Annual meeting
        • First paediatric antituberculosis drug optimization (PADO TB 1) meeting, February 2019
        • 2018 Annual Meeting
        • Committing to ending TB in children, adolescents and families, 24 September 2018
        • 2017 Annual Meeting
        • 2016 Annual Meeting
        • 2014 Annual Meeting
        • 2013 Annual Meeting
        • Annual meeting of the Childhood TB Subgroup, Kuala Lumpur, Malaysia, 11 November 2012
        • Past Events
        • 2022 Virtual annual meeting
        • Meetings Child & Adolescent TB Working Group
          • 2023 Annual Meeting
        • Objectives
        • Core Team Child & Adolescent TB
        • Structure
          • Chair of the Child & Adolescent TB Working Group.
          • Vice Chair of the Child & Adolescent TB Working Group Working Group
          • Secretariat - Child & Adolescent TB Working Group.
        • Repository of Resources
        • Publications
          • Ethambutol efficacy and toxicity:
          • Roadmap towards ending TB in children and adolescents 2nd Edition
          • Roadmap towards ending TB in children and adolescents 3rd Edition
      • End TB Transmission Initiative
        • ETTi Working Group Team
        • ETTi - Technical Readings
        • ETTi - TB and Airborne Workshops & Webinars
        • ETTi - TB and Airborne IPC Guidance
        • ETTi - Virtual library of good practices
        • ETTi - Meetings & Events
        • ETTi - Newsletters & Social Media
        • ETTi - Feedback
      • Global Drug-resistant TB Initiative
        • Resources
        • GDI Governance
        • GDI Mission
        • GDI Terms of Reference
        • What's new at GDI
        • GDI Structure
          • Chair of the GDI Working Group
          • Vice Chair of the GDI Working Group
        • GDI Meetings
      • Global Laboratory Initiative (GLI)
        • About Us
        • GLI Mission
        • GLI News
        • GLI Guidance and Tools
          • GLI Specimen Referral Toolkit
          • TB Laboratory Accreditation
          • GLI Quick Guide to TB Diagnostics Connectivity Solutions
          • GLI Stepwise Process towards TB Laboratory Accreditation
          • GLI TB Laboratory Safety Handbook
          • GLI guide for the interpretation and reporting of line probe assays
          • Planning and Budgeting Tool for TB and drug resistant TB testing
          • Practical Guide to Implementation of Truenat tests
          • Practical implementation of LF-LAM for detection of active TB in people living with HIV
        • Standard Operating Procedures (SOPs)
        • Training Packages
          • Diagnostic network strengthening and Xpert MTB/RIF (Ultra) implementation
          • Programme Modules for Diagnostic Network Strengthening
          • XPERT MTB/RIF
        • Partner Links
        • Join Us
        • GLI EQA Dashboard
        • GLI working group - Team members
        • MEETINGS & EVENTS
          • GLI Webinars
          • Implementing tNGS for Detection of Drug-Resistant TB in High Burden Countries
      • New Diagnostics
        • Task Force on Biomarkers for TB point-of-care tests
          • Bm2Dx TB Biomarker database
        • Task Force on NGS and DST
          • TPP on next-generation DST at peripheral level - Update
          • Advocacy fact sheet
          • Data Sharing
            • 1st NDWG workshop on sequencing data sharing
            • 2nd NDWG Workshop - Data sharing to improve management of drug resistant TB
        • Task Force on TBI and test of progression
          • Model to evaluate the impact of a test for incipient TB
          • TPP and Framework for evaluation for a test of progression of LTBI
            • 2nd Expert Workshop on the development of tests for progression of latent tuberculosis infection (LTBI) to active disease
            • Resources on TBI
        • News
        • Task Force on Community Engagement
        • New Diagnostics Working Group Resources
          • Guidelines & Policies
          • Publications
          • Scientific Articles
          • News Archive
          • Newsletters
          • Links
        • NDWG - About us
        • NDWG - Our Team
        • NDWG - Task Forces
        • NDWG - Publications
        • Meetings & Events
          • NDWG Annual Meeting 2021
          • NDWG Annual Meeting 2020
          • NDWG Annual Meeting 2019
          • NDWG Annual Meeting 2018
          • NDWG Annual Meeting 2017
          • NDWG Annual Meeting 2016
          • NDWG Annual Meeting 2015
          • NDWG Annual Meeting 2014
          • NDWG Annual Meeting 2013
          • NDWG Annual Meeting 2012
          • NDWG Annual Meeting 2011
          • NDWG Annual Meeting 2010
          • NDWG Annual Meeting 2009
          • NDWG Annual Meeting 2008
          • NDWG Annual Meeting 2007
          • NDWG Annual Meeting 2006
          • Events Archive
          • NDWG Annual Meeting 2004
      • New TB Drugs
      • New TB Vaccines
      • Public-Private Mix (PPM) For TB Care and Prevention
        • Core Group
        • Objectives
        • PPM Learning network to End TB launched at the Union World Conference on Lung Health
        • PPM Working Group News
          • 16th Global PPM Working Group Meeting - News Report
          • 17th Global PPM Working Group Meeting - News Report
          • NEWS ARCHIVE
            • 14th Global PPM Working Group Meeting - Report News
          • New Publication
        • PPM Working Group Key Documents
        • PPM Working Group Meetings
          • 17th Global PPM Working Group Meeting
          • 16th Global PPM Working Group Meeting
          • 15th Global PPM Working Group Meeting
          • 18TH GLOBAL PPM WORKING GROUP MEETING
          • Mini-Meet PPM Group May 2021
          • WHO consultation on enhanced TB-PPM Dashboards with seven PPM priority countries
          • 19TH GLOBAL PPM WORKING GROUP MEETING
          • 14th Global PPM Working Group Meeting
        • Structure
          • Chair of the PPM Working Group
          • The Secretariat - PPM Working Group
          • Vice Chair of the PPM Working Group
        • 13th PPM Working Group Meeting
  • What we do
    • Advocate to #EndTB
      • Advocacy and Communications
        • BCG
        • Key Targets and Commitments
        • Stop TB in the News
          • One World TB Summit
          • Global Impact of Tuberculosis - Press Conference
          • Bedaquiline Agreement
          • UN HLM on TB media coverage
          • Global Drug Facility (GDF) announced price reductions up to 55% for bedaquiline
          • Press tour to Mozambique
          • Stop TB Head and TB Champion raise awareness of link between TB and AMR
      • World TB Day
        • World TB Day 2024
          • Your Events
          • Social Media Challenge
          • Wall of Fame
          • Light up For TB
        • World TB Day 2023
          • Your Events
          • Social Media Challenge
          • Wall fo Fame
        • World TB Day 2022
          • DO IT YOURSELF
          • Digital Billboards
          • Wall of Fame
          • Your event
        • World TB Day 2021
          • 2021 Highlights
          • About the 2021 campaign
          • Do It Yourself
          • Join the Campaign
          • Your Photos
        • World TB Day 2020
          • Quick Actions
          • More Actions
          • Campaign Materials
          • Events Near You
          • Your Photos
          • TB AND COVID-19
      • UN High-Level Meeting on TB
        • UN High-Level Meeting on TB 2023
      • Global Fund Disease Split
      • Global Plan to End TB
        • Global Plan to End TB 2023-2030
      • Step up for TB: National TB Policies
      • Tuberculosis Research Funding Trends, 2005-2022
      • Hello Kitty
      • The G20
    • Prioritise People, Human Rights & Gender
      • Fund TB communities & civil society
      • Community-Led Monitoring
      • Promote Human Rights in TB
        • Declaration of Rights of People Affected by TB
        • TB Human Rights Discussion Group
      • Support Gender Equity in TB
      • End TB Stigma
      • Reach Key & Vulnerable Populations
      • Empower TB Affected Communities & Civil Society
      • Strengthen Country-level Partnerships
        • Partnering Process
          • Partnership Building
          • Partnership Exploration
          • Partnership Maintenance
      • Award those who care
    • Accelerate TB innovations
      • TB REACH
        • How TB REACH Works
        • The Team
        • TB REACH Impact
          • TBR Gender and Women’s Empowerment
        • Catalyzing Diagnostic Use
          • TB REACH Xpert Budget Estimation Tool
        • Ground Up Innovation
        • Monitoring Success
        • Waves of funding
          • Wave 10
          • Wave 9
          • Wave 8
            • TB REACH Wave 8 Application
            • TB REACH Wave 8 Proposal Review Committee Application
            • Wave 8 Application Resources
          • Wave 7
          • Wave 6
            • Wave 6 Digital Adherence Technology Projects
          • Wave 5
            • Approved Projects
            • Project Summaries
            • Results
          • Wave 4
            • Approved Projects
            • Project Summaries
            • Results
          • Wave 3
            • Approved Projects
            • Project Summaries
            • Results
          • Wave 2
            • Approved Projects
            • Project Summaries
            • Results
          • Wave 1
            • Approved Projects
            • Project Summaries
            • Results
          • Wave 11
        • TB Reach publications
      • Re-imagining TB care
      • Digital Health Technology Hub
        • AI-POWERED COUGH SOUND ANALYSIS AND MONITORING
        • AI-Powered Computer-Aided Detection (CAD) Software
          • Case Studies
          • Evaluations
          • Focus Group on AI-based Imaging for TB
            • CAD and X-ray experience sharing from India
            • FG-AITB Webinar 5 - Pakistan Experience
            • FG-AITB Webinar 6 - Cambodia Experience
            • FG-AITB Webinar 7 - Vietnam Experience
            • FG-AITB Webinar 8 - Uganda Experience
            • FG-AITB Webinar 9- Janna Health Foundation Experiences in Nigeria
            • Implementing CAD and Ultra-Portable X-ray in Nigeria
          • Resources for implementing CAD and XRay
            • CAD and X-ray Practical Implementation Guide
            • CAD and X-ray Training Modules
        • Community-Led Monitoring Tools
        • Diagnostics Connectivity Solutions
        • Digital Adherence Technologies
        • Global DAT Task Force
      • The Introducing New Tools Project
        • Artificial intelligence-powered computer-aided detection (CAD) software
        • Country Experiences
        • Rapid molecular diagnostics for use at peripheral level
          • Truenat training modules
        • TB preventative therapy (TPT)
        • Ultra-portable digital X-ray systems
        • Interferon Gamma Release Assays for detection of TB infection
        • Digital treatment adherence and support technologies
        • Diagnostics connectivity solutions
        • Targeted next-generation sequencing
        • Resources for implementation
        • Access pricing
    • Facilitate Access to TB Drugs & Diagnostics
      • Global Drug Facility (GDF)
        • Mission
        • Market & Partner Coordination
          • TB Medicines Dashboard
          • Stakeholder coordination and TPMAT
        • Buyers
          • Plan an Order
          • Place an Order
            • Medicines
            • Diagnostics
          • Track an Order
        • Suppliers
          • How to become a StopTB/GDF supplier
            • Medicines
            • Suppliers of TB Diagnostics, Medical Devices & Laboratory supplies
          • Quality Assurance
          • Procurement Notices
            • Archived procurement notices
          • GDF Supplier Meetings
          • Supplier Information
        • New Tools
          • Diagnostics
          • Access pediatric formulations
          • Bedaquiline
            • Bedaquiline Donation Programme
          • Delamanid
          • Access Pretomanid
          • Access TPT
        • Technical Assistance
        • Products Catalog
    • Provide technical support and capacity building
  • Partner With Us
    • Why Become a Partner
    • How to become a Partner
    • The benefits of partnership
    • Our Partners
    • Joining Forces to #EndTB
      • Additional resources
  • Resources
    • World TB Day
    • Interactive TB data
      • Interactive Country Dashboard
      • Interactive Map Dashboard
      • Treatment Dashboard
    • Digital TB Assessment
    • GDF Resources
    • TB & COVID
    • Publications
    • Governance of TB programs
    • UNHLM Targets & Commitments
    • COMMUNITIES, RIGHTS AND GENDER
    • At A Glance
    • What is Tuberculosis?
  • News
    • News
    • Events
    • Newsletter
  • Donate

The Stop TB Partnership

Global Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland

Find us on Facebook Find us on Twitter Find us on Instagram Find us on LinkedIn

Useful links

  • Careers
  • Sitemap
  • FAQ
  • Terms of Use
  • Contact
  • Privacy Policy

Suscribe to stay informed

Sign up to learn more about TB and events.

© 2019 Stop TB Partnership - hosted by UNOPS
access